J. Joshua Smith, MD, PhD

J. Joshua Smith, MD, PhD, FACS

Surgical Oncologist

Titles

Associate Attending Surgeon

Clinical Expertise

Rectal Cancer; Colon Cancer; Anal Dysplasia, High-Grade Intraepithelial Lesion (HSIL), Low-Grade Intraepithelial Lesion (LSIL), Anal Condylomata, Anal Polyps, Anal Cancer; Minimally Invasive Surgical Approaches; Preservation of Bowel, Bladder and Sexual Function; Colorectal Liver Metastases; Rectal Cancer Clinical Trials

Share

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Monday through Friday, 8:00 a.m. to 6:00 p.m., (Eastern time)
Accepted Insurance Providers

Dr. Smith accepts the following list of insurance providers. Select your insurance provider to see more details.

Aetna

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (City of NY retirees only, starting 7/1/23)

Payor Type:
In Network Coverage Type(s): PPO

Blue Cross Blue Shield Federal Employee Program

Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO

Blue Cross Blue Shield New York

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS

Blue Cross Health Plus

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Carrum Health

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

Cigna

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Connecticare

Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO

Emblem

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Emblem Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Emblem Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Empire Blue Cross Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN

Empire Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Fidelis

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO

Fidelis Managed Medicaid & HARP

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Fidelis Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO

First Health

Payor Type:
In Network Coverage Type(s): PPO

Healthfirst

Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Healthfirst Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO, PPO

Healthsmart

Payor Type: Commercial
In Network Coverage Type(s): PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

Payor Type: Commercial
In Network Coverage Type(s): HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Husky CT Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Magnacare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO

Medicare Part A&B (traditional Medicare)

Payor Type:
In Network Coverage Type(s): Federal Government

Multiplan/Beech Street/PHCS

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

MVP

Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP

Non-Participating Plans with Out of Network Benefits

Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

Payor Type:
In Network Coverage Type(s): TBD

Oscar

Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO

Oxford

Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO

Qualcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Straight NJ Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Straight NY Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Tricare

Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO

UMR

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS

United Healthcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

World Trade Center Health Program (WTC)

Payor Type: Commercial
In Network Coverage Type(s): State Government

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, University of Texas Medical School at Houston; PhD, Vanderbilt University Medical Center

Residencies

General Surgery - Vanderbilt University Medical Center

Fellowships

Complex Surgical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

American Board of Surgery

As a surgeon on the Colorectal Surgery Service, I care for people with rectal, colon, and anal cancer. Patient care in my practice revolves around selecting treatment options that will optimize patient outcomes, enhance quality of life, and adhere to a patient-centered approach. I conduct research on these diseases and have special training in surgical oncology with special emphasis in colorectal surgery. I received my MD degree from the University of Texas Medical School at Houston and my PhD degree in Cell and Developmental Biology from Vanderbilt University Medical Center, where I also completed my residency.

Read more

In 2013, I joined Memorial Sloan Kettering Cancer Center (MSK) as a fellow in complex surgical oncology. I served as Chief Administrative Fellow for the Department of Surgery from 2014 to 2015. At MSK I have been a co-leader on the topic of watch-and-wait after clinical complete response to neoadjuvant therapy for rectal cancer patients on our Colorectal Disease Management Team. I am actively working to improve our understanding of this management strategy for rectal cancer patients on and off trial. Currently, I am a co-investigator on Dr. Paul Rommesser’s novel trial in rectal cancer patients. Additionally, I serve on the Rectal-Anal Task Force of the National Cancer Institute’s Gastrointestinal Steering Committee and serve on the Alliance for Clinical Trials GI Surgery Working Group.

While I focus on caring for people with rectal and colon cancer,I also research how to improve responses to standard treatments for these diseases. I spend significant time doing basic and translational research in the laboratory of Charles Sawyers. My focus there is to develop better models to study rectal cancer and to uncover targeted treatments for people with rectal and colon cancer who do not respond to standard treatments. This type of research requires that I investigate the basic mechanisms and predictive markers that we can assess in the tumors of our patients with colorectal cancer. In particular, I study Smad4 loss to identify people at risk for their cancer returning.

In the past four years, I have been heavily involved with Dr. Garcia-Aguilar in administration of his National Institutes of Health funded trial, Organ Preservation in Rectal Adenocarcinoma, for which I am an active site co-lead. We are looking into the molecular mechanisms of poor response to standard neoadjuvant chemoradiation in locally advanced rectal cancer. Furthermore, we have proposed a novel method of assessing response. We are examining this in a prospective manner to find a more precise and individualized approach to caring for people with rectal cancer.

Patient care in my practice revolves around selecting treatment options that will optimize patient outcomes, enhance quality of life, and adhere to a patient-centered approach

-Dr. Smith

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Colorectal Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

View Dr. Smith's Research

Publications on PubMed

Visit PubMed for a full listing of Dr. Smith’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

J. Joshua Smith discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures